- Home
- GILD vs PANW Comparison
GILD vs PANW Comparison
Compare GILD & PANW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILD
- PANW
- Stock Information
- Founded
- GILD 1987
- PANW 2005
- Country
- GILD United States
- PANW United States
- Employees
- GILD N/A
- PANW N/A
- Industry
- GILD Biotechnology: Biological Products (No Diagnostic Substances)
- PANW Computer peripheral equipment
- Sector
- GILD Health Care
- PANW Technology
- Exchange
- GILD Nasdaq
- PANW Nasdaq
- Market Cap
- GILD 110.9B
- PANW 132.3B
- IPO Year
- GILD 1992
- PANW 2012
- Fundamental
- Price
- GILD $88.46
- PANW $386.83
- Analyst Decision
- GILD Buy
- PANW Buy
- Analyst Count
- GILD 24
- PANW 41
- Target Price
- GILD $93.91
- PANW $390.87
- AVG Volume (30 Days)
- GILD 7.3M
- PANW 1.9M
- Earning Date
- GILD 11-06-2024
- PANW 11-20-2024
- Dividend Yield
- GILD 3.48%
- PANW N/A
- EPS Growth
- GILD N/A
- PANW 468.75
- EPS
- GILD 0.10
- PANW 7.28
- Revenue
- GILD $28,299,000,000.00
- PANW $8,027,500,000.00
- Revenue This Year
- GILD $5.71
- PANW $16.00
- Revenue Next Year
- GILD $0.37
- PANW $15.22
- P/E Ratio
- GILD $911.55
- PANW $53.14
- Revenue Growth
- GILD 3.31
- PANW 16.46
- 52 Week Low
- GILD $62.07
- PANW $249.56
- 52 Week High
- GILD $98.90
- PANW $408.53
- Technical
- Relative Strength Index (RSI)
- GILD 46.13
- PANW 58.63
- Support Level
- GILD $89.01
- PANW $385.57
- Resistance Level
- GILD $98.90
- PANW $408.53
- Average True Range (ATR)
- GILD 2.11
- PANW 8.61
- MACD
- GILD -0.63
- PANW 0.69
- Stochastic Oscillator
- GILD 8.58
- PANW 58.69
About GILD Gilead Sciences Inc.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
About PANW Palo Alto Networks Inc.
Palo Alto Networks is a platform-based cybersecurity vendor with product offerings covering network security, cloud security, and security operations. The California-based firm has more than 80,000 enterprise customers across the world, including more than three fourths of the Global 2000.